Skip Navigation LinksHome > April 2010 - Volume 38 - Issue 4 > The efficacy and safety of proton pump inhibitors vs histami...
Critical Care Medicine:
doi: 10.1097/CCM.0b013e3181d69ccf
Review Articles

The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: A meta-analysis

Lin, Pei-Chin MSCP; Chang, Chia-Hsuin MD, ScD; Hsu, Ping-I MD; Tseng, Pi-Lai MS; Huang, Yaw-Bin PhD

Collapse Box

Abstract

Objective: To examine the efficacy and safety of proton pump inhibitors in comparison with histamine-2 receptor antagonists for stress-related upper gastrointestinal bleeding prophylaxis among critical care patients.

Data Sources: PubMed, EMBASE, Cochrane Library, and ClinicalTrials.gov.

Study Selection: Randomized, controlled trials that directly compare proton pump inhibitors with histamine-2 receptor antagonists in prevention of stress-related upper gastrointestinal bleeding in intensive care unit patients published before May 30, 2008.

Data Extraction: Two reviewers independently applied selection criteria, performed quality assessment, and extracted data. The primary outcome was the incidence of stress-related upper gastrointestinal bleeding, and the secondary outcome measures were the incidence of pneumonia and intensive care unit mortality.

Data Synthesis: The random effect model was used to estimate the pooled risk difference between two treatment arms irrespective of drug, dosage, and route of administration.

Results: We identified seven randomized, controlled trials with a total of 936 patients for planned comparison. The overall pooled risk difference (95% confidence interval; p value; I2 statistics) of stress-related upper gastrointestinal bleeding comparing proton pump inhibitors vs. histamine-2 receptor antagonists was −0.04 (95% confidence interval, −0.09-0.01; p = .08; I2 = 66%). In the sensitivity analysis, removing the Levy study significantly reduced the heterogeneity (from I2 = 66% to I2 = 26%) and shifted the overall risk difference closer to the null (pooled risk difference, −0.02; 95% confidence interval, −0.05-0.01; p = .19). There was no difference between proton pump inhibitors and histamine-2 receptor antagonists therapy in the risk of pneumonia and intensive care unit mortality, with pooled risk differences of 0.00 (95% confidence interval, −0.04-0.05; p = .86; I2 = 0%) and 0.02 (95% confidence interval, −0.04-0.08; p = .50; I2 = 0%), respectively.

Conclusions: This meta-analysis did not find strong evidence that proton pump inhibitors were different from histamine-2 receptor antagonists in terms of stress-related upper gastrointestinal bleeding prophylaxis, pneumonia, and mortality among patients admitted to intensive care units. Because of limited trial data, future well-designed and powerful randomized, clinical trials are warranted.

© 2010 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.